Francesca Lazzaroni

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Pathogenic and Clinical Implications of the 2-Way Interplay Between Clonal Hematopoiesis of Indeterminate Potential and Multiple Myeloma.

Pathogenic and Clinical Implications of the 2-Way Interplay Between Clonal Hematopoiesis of Indeterminate Potential and Multiple Myeloma.

Journal: Clinical lymphoma, myeloma & leukemia
Published: February 17, 2026

Bone marrow microenvironment in autoimmune hemolytic anemia: from trephine biopsy to single cell RNA sequencing.

Bone marrow microenvironment in autoimmune hemolytic anemia: from trephine biopsy to single cell RNA sequencing.

Journal: Signal transduction and targeted therapy
Published: November 25, 2024

Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes.

Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes.

Journal: Blood
Published: July 19, 2024

Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma.

Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma.

Journal: Blood
Published: June 05, 2024

Single-cell and clonal analysis of AL amyloidosis plasma cells and their bone marrow microenvironment.

Single-cell and clonal analysis of AL amyloidosis plasma cells and their bone marrow microenvironment.

Journal: Blood
Published: March 21, 2024

Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis.

Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis.

Journal: Blood advances
Published: December 13, 2023

KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation.

KRIT1 heterozygous mutations are sufficient to induce a pathological phenotype in patient-derived iPSC models of cerebral cavernous malformation.

Journal: Cell reports
Published: December 09, 2023

Proteomics on human cerebral cavernous malformations reveals novel biomarkers in neurovascular dysfunction for the disease pathology.

Proteomics on human cerebral cavernous malformations reveals novel biomarkers in neurovascular dysfunction for the disease pathology.

Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 17, 2023

TENT5C/FAM46C modulation in vivo reveals a trade-off between antibody secretion and tumor growth in multiple myeloma.

TENT5C/FAM46C modulation in vivo reveals a trade-off between antibody secretion and tumor growth in multiple myeloma.

Journal: Haematologica
Published: September 18, 2023

Circulating biomarkers in familial cerebral cavernous malformation.

Circulating biomarkers in familial cerebral cavernous malformation.

Journal: EBioMedicine
Published: August 02, 2023

Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple Myeloma.

Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple Myeloma.

Journal: International journal of molecular sciences
Published: November 15, 2022

Mapping endothelial-cell diversity in cerebral cavernous malformations at single-cell resolution.

Mapping endothelial-cell diversity in cerebral cavernous malformations at single-cell resolution.

Journal: eLife
Published: July 24, 2020
Showing 1-12 of 17

Last Updated: 09/26/2026